Filter by
- (-) Niger (12)
- Algeria (3)
- Angola (3)
- Benin (3)
- Botswana (4)
- Burkina Faso (5)
- Burundi (6)
- Cabo Verde (5)
- Cameroon (2)
- Central African Republic (1)
- Chad (4)
- Comoros (1)
- Congo (1)
- Cote d'Ivoire (2)
- Democratic Republic of the Congo (5)
- Equatorial Guinea (3)
- Eritrea (2)
- Eswatini (3)
- Ethiopia (7)
- Gabon (2)
- Gambia (4)
- Ghana (4)
- Guinea (4)
- Guinea-Bissau (2)
- Kenya (6)
- Lesotho (3)
- Liberia (1)
- Madagascar (1)
- Malawi (2)
- Mali (3)
- Mauritania (2)
- Mauritius (5)
- Mozambique (11)
- Namibia (4)
- Nigeria (4)
- Rwanda (6)
- Sao Tome and Principe (2)
- Senegal (4)
- Seychelles (1)
- Sierra Leone (4)
- South Africa (2)
- South Sudan (3)
- Togo (1)
- Uganda (6)
- United Republic of Tanzania (5)
- Zambia (2)
- Zimbabwe (4)
- 3732 (0)
- Health and care workforce (8)
- Health facilities, service delivery (1)
- Health Information Systems (5)
- Health Insurance, Social Protection (8)
- (-) Health products (10)
- Institutions and mandate (5)
- Protection of specific groups (6)
- Public Health (2)
- 3806 (0)
- Specific health area or disease (8)
Décret No 2022-915/PRN/MSP/P/AS du 30 novembre 2022, portant approbation des statuts de l'Agence Nigérienne de Règlementation du secteur Pharmaceutique
The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.
Décret No 2021-279/PRN/MSP/O/AS du 29 avril 2021, adoptant la Politique Pharmaceutique Nationale
The Decree adopts the national pharmaceutical policy. This policy sets out and prioritizes the medium- and long-term goals set by the State for the pharmaceutical sector, and defines the main strategies for achieving them. It provides a framework within which pharmaceutical sector activities are coordinated. It covers both the public and private sectors, and involves all the main players in the pharmaceutical sector. It is an integral part of national health policy.
Règlement No 04/2020/CM/UEMOA relatif aux procédures d’homologation des produits pharmaceutiques à usage humain
The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.
Arrêté No 110 MSP/SG/DGSP/MT portant révision de la Liste Nationale des Médicaments Essentiels
The decree revises Niger's national list of essential medicines.
Arrêté No 0152/MSP/DGSP/DPH/MT, portant création du Comité multisectoriel pour la lutte contre la contrefaçon et la vente illicite des médicaments et autres produits pharmaceutique
The decree creates a multi-sectoral committee to combat counterfeiting and the illicit sale of medicines and other pharmaceutical products, reporting to Niger's Minister of Public Health.
Arrêté No 69/MSP/DGSP/DPHLMT, portant création du Comité d’Experts chargé de l’évaluation technique des dossiers de demande d’homologation des produits pharmaceutiques à usage humain
The decree establishes a Committee of Experts in charge of technical evaluation, whose mission is to carry out the technical evaluation of applications for registration of pharmaceutical products for human use. It also gives an opinion on the quality, safety and efficacy of pharmaceutical products for human use submitted for registration.
Arrêté No 68/MSP/DGSP/DPHLMT, portant création de la Commission Nationale du Médicament (CNM)
The decree creates the Commission Nationale du Médicament (CNM) for human use, whose mission is to validate the work of the Expert Committee responsible for the technical evaluation of applications for marketing authorization for pharmaceutical products for human use. It also gives a final opinion on marketing authorization applications; applications for renewal, extension of variation and transfer of marketing authorization; temporary suspension of marketing authorization; and proposals for definitive withdrawal of marketing authorization.
Arrêté No 466/MSP/DGSP/DPHL/MT, portant additif à l’arrêté n° 065/MSP/DGSP/DPHL/MT du 09 février 2009 portant Liste Nationale des Médicaments essentiels (LNME)
The decree revises Niger's national list of essential medicines from 2009
Constitution de de la République du Niger
The Constitution was promulgated by Decree No 2010-754 of 25 November 2010. It includes 185 articles addressing a wide array of issues including, among other things, human rights and duties and institutional arrangements.
Règlement No 06/2010/CM/UEMOA relatif aux procédures d’homologation des produits pharmaceutiques à usage humain
The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.
Constitution
The Constitution of Niger (2010) is structured into several titles, each addressing different aspects of the state's governance and the rights of its citizens. The document begins with a Preamble, followed by Title I: The State and Sovereignty, which outlines the fundamental principles of the Republic of Niger. Title II: Rights and Duties of the Human Person includes various articles on individual rights, including health rights. Title III: Executive Power details the roles and responsibilities of the President and the Government. Title IV: Legislative Power focuses on the functions of the National Assembly. Title V: Relations Between Executive and Legislative Powers describes the interaction between these branches. Title VI: Judicial Power covers the judiciary's independence and structure. Title VII: Economic, Social, and Cultural Development outlines the state's development policies. Title VIII: The Higher Council of Communication addresses media and communication regulations. Title IX: Local Authorities discusses decentralization and local governance. Title X: Treaties and International Agreements covers the process of treaty ratification. Title XI: Cooperation and Association with States focuses on international cooperation. Title XII: Revision details the process for amending the Constitution. Title XIII: Transitional Provisions and Title XIV: Final Provisions conclude the document. Articles 12 and 13 specifically refer to health rights. Article 12 states that everyone has the right to health, and Article 13 emphasizes the state's duty to create conditions ensuring access to medical services and assistance in case of illness.
Ordonnance No 97-002 du 10 janvier 1997 portant législation pharmaceutique
The Ordinance provides legislation governing pharmacy. The ordinance regulates the classification of medicines, the registration of medicines, the dispensing of medicines, dietary products, cosmetics, the rules for practicing the profession of pharmacist, the dispensing of medicines by doctors and other aspects.